Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126518391 | 12651839 | 1 | I | 20160215 | 20160802 | 20160815 | 20160815 | EXP | GB-PRESTIUM-2016RN000333 | RENAISSANCE | 81.00 | YR | F | Y | 0.00000 | 20160815 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126518391 | 12651839 | 1 | PS | ACYCLOVIR. | ACYCLOVIR | 1 | UNK | U | 20089 | TABLET | |||||||||
| 126518391 | 12651839 | 2 | C | RAMIPRIL. | RAMIPRIL | 1 | 2.5 MG, QD | 0 | 2.5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126518391 | 12651839 | 1 | Herpes zoster |
| 126518391 | 12651839 | 2 | Blood pressure abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126518391 | 12651839 | OT |
| 126518391 | 12651839 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126518391 | 12651839 | Dyspnoea exertional | |
| 126518391 | 12651839 | Faeces discoloured | |
| 126518391 | 12651839 | Fatigue | |
| 126518391 | 12651839 | Pallor | |
| 126518391 | 12651839 | Small intestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126518391 | 12651839 | 1 | 20160204 | 0 |